We established a mouse HCC model with NQO1 overexpression (Figure 8F), and the results indicated that the NQO1 + aPD‐1 + lenvatinib + Plerixafor group exhibited significantly smaller tumor volumes, with stronger effects compared to other groups (Figure 8G,H). Here, NQO1 is linked to hepatocellular carcinoma.